A Study of DCR-STAT3 in Adults With Solid Tumors

NCT06098651 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor, Adult
Refractory Tumor

Interventions

DRUG: DCR-STAT3

Sponsor

Dicerna Pharmaceuticals, Inc., a Novo Nordisk company